AzTrials
AzTrials

Out-of-hospital Cardiac Arrest (OHCA)NCT07622082

Out-of-hospital Cardiac Arrest Epidemiology and Outcomes in Western Lithuania 2022-2028

An observational study of Out-of-hospital Cardiac Arrest (OHCA), run by Lithuanian University of Health Sciences.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Out-of-hospital cardiac arrest rate is common problem, because of high mortality rate. It is not clear incidence rate, epidemiology and outcomes in Lithuania Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Out-of-hospital Cardiac Arrest (OHCA)
What is being tested?
Protocol based
How many people
4,000 participants
Where
No sites listed yet
Study dates
1 Sep 2026to 1 Jan 2030
How long will I take part?
1 Year
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: only adults

Who may be able to join

  • people experiencing out-of-hospital cardiac arrest

Who cannot join

  • all others

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Linas Darginavicius, PhD contact

+37065262929

linas.darginavicius@lsmu.lt

Deimante Baksevice, MD contact

deimante.baksevice@lsmu.lt

About this study

Official title: Prehospital Processess Optimization and Emergency Medical Services' Dispatcher's Actions Modeling Impact on Quality of Cardiopulmonary Resuscitation After Sudden Cardiac Arrest

Out-of-hospital cardiac arrest rate is common problem, because of high mortality rate. It is not clear incidence rate, epidemiology and outcomes in Lithuania

Read the detailed description

This data reported according to UTSTEIN guidelines could be compared with other countries from the region although not much data is available, but it will be a baseline for future references about processes in patient management, demographics, incidence rate and OHCA outcomes.

Being tested
Protocol based
Medical subject headings
Out-of-Hospital Cardiac Arrest

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Protocol basedBehavioural

    change of EMS dispatcher protocol

Study groups in NCT07622082
Study groupRoleWhat they receive
Subgroup 2021-2025Subgroup before change of dispatcher protocol
Subgroup 2026-2028Subgroup after change of dispatcher protocol
Receives: Behavioral: Protocol based

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The detection of death will be shorter

    Measured: 1st Jan 2030

Secondary outcomes (1)
  1. The survival rate will increase

    Measured: 1st Jan 2030

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Jun 2026
  2. Study start1 Sep 2026 (estimated)
  3. Primary completion31 Dec 2028 (estimated)
  4. Study completion1 Jan 2030 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Other
Enrolment
4,000 participants (estimated)
Target duration
1 Year
IDs, dates and publications
ClinicalTrials.gov ID
NCT07622082
Sponsor's protocol ID
LITCPR
Status last verified
May 2026
First submitted
27 May 2026
Last updated
2 Jun 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Out-of-hospital Cardiac Arrest (OHCA), run by Lithuanian University of Health Sciences.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 2 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Linas Darginavicius, PhD (+37065262929, linas.darginavicius@lsmu.lt), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The detection of death will be shorter (time frame: 1st Jan 2030). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in